Novo Nordisk Aktie
60,88
EUR
+0,88
EUR
+1,47
%
60,00
EUR
-1,26
EUR
-2,06
%
Werbung
Novo Nordisk Aktie Analyse
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.03.25 | Novo Nordisk Buy | UBS AG | |
04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
03.03.25 | Novo Nordisk Buy | UBS AG | |
26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
24.02.25 | Novo Nordisk Buy | UBS AG | |
20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.02.25 | Novo Nordisk Buy | UBS AG | |
17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | UBS AG | |
10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Halten | DZ BANK | |
06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
06.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
05.02.25 | Novo Nordisk Buy | UBS AG | |
05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.02.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.01.25 | Novo Nordisk Buy | UBS AG | |
27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.01.25 | Novo Nordisk Buy | UBS AG | |
24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
21.01.25 | Novo Nordisk Buy | UBS AG | |
17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.01.25 | Novo Nordisk Buy | UBS AG | |
16.01.25 | Novo Nordisk Buy | UBS AG | |
15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
13.01.25 | Novo Nordisk Buy | UBS AG | |
10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.01.25 | Novo Nordisk Buy | UBS AG | |
07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Werbung
Werbung